Acino board accepts $439m acquisition offer
This article was originally published in Scrip
Executive Summary
Avista Capital Partners and Nordic Capital have put forward a joint offer to acquire Swiss pharma company Acino for CHF115 ($127) per share, or around $439m. Acino's board has unanimously resolved to support the offer and is urging the company's shareholders to do the same.